Vertex announced plans to acquire Alpine Immune Sciences for $4.9 billion, primarily for its experimental drug povetacicept to treat IgA nephropathy. Vertex will pay $65 per...
Vertex is a global biotech company that invests in scientific innovation to create medicines for people with serious diseases. The company has multiple medications approved to...